Main publications
Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, Domenico Milano, Elisa Giacomini, Federico Falchi, Andrea Balboni, Marcella Manerba, Fulvia Farabegoli, Francesca De Franco, Janet Robertson, Saverio Minucci, Isabella Pallavicini, Giuseppina Di Stefano, Stefania Girotto, Roberto Pellicciari, and Andrea Cavalli (2019). Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 165, p. 80-92, ISSN: 0223-5234, doi: 10.1016/j.ejmech.2019.01.008.
Falchi, Federico, Giacomini, Elisa, Masini, Tiziana, Boutard, Nicolas, Di Ianni, Lorenza, Manerba, Marcella, Farabegoli, Fulvia, Rossini, Lara, Robertson, Janet, Minucci, Saverio, Pallavicini, Isabella, Di Stefano, Giuseppina, Roberti, Marinella, Pellicciari, Roberto, Cavalli, Andrea (2017). Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors. ACS CHEMICAL BIOLOGY, vol. 12, p. 2491-2497, ISSN: 1554-8929, doi: 10.1021/acschembio.7b00707.
Rupiani S.; Guidotti L.; Manerba M.; Di Ianni L.; Giacomini E.; Falchi F.; Di Stefano G.; Roberti M.; Recanatini M. (2016). Synthesis of natural Urolithin M6, a Galloflavin mimetic as potential inhibitor of Lactate dehydrogenase A. ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 14, p. 10981-10987. DOI: 10.1039/c6ob01977c.
Pizzirani D., Roberti M., Grimaudo S., Di Cristina A., Pipitone R.M., Tolomeo M., Recanatini M. (2009). Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells. JOURNAL OF MEDICINAL CHEMISTRY, vol. 52, p. 6936-6940. doi: 10.1021/jm900907s.